Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

    172 Citationer (Scopus)

    Abstract

    Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.
    OriginalsprogEngelsk
    TidsskriftJournal of Thrombosis and Haemostasis
    Vol/bind9
    Udgave nummer8
    Sider (fra-til)1460-7
    Antal sider8
    ISSN1538-7933
    DOI
    StatusUdgivet - 1 aug. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort'. Sammen danner de et unikt fingeraftryk.

    Citationsformater